Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature

Strongyloides stercoralis infections may be documented in low‐endemicity areas, particularly in immigrants from endemic areas. The case of a patient from Bangladesh, an immigrant to Italy who developed a S. stercoralis infection after allogeneic stem cell transplant, is described, and 7 further cases are reviewed. Because of the atypical clinical presentation, the low predictive role of the eosinophil count, and the low sensitivity of the microbiological tests, diagnosis of strongyloidiasis is a challenging problem. When a case of S. stercoralis infection is suspected, previous exposure may be the only clue to guide the diagnostic approach.

[1]  J. Briones,et al.  Fatal Strongyloides Hyperinfection Complicating a Gram-Negative Sepsis after Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature , 2013, Case reports in hematology.

[2]  Rogan Lee,et al.  Seroepidemiology of Strongyloides stercoralis in Dhaka, Bangladesh , 2012, Parasitology.

[3]  E. Gotuzzo,et al.  Update on Strongyloidiasis in the Immunocompromised Host , 2011, Current infectious disease reports.

[4]  A. Oberoi,et al.  Strongyloides stercoralis infection in a patient undergoing allogeneic stem cell transplantation. , 2010, Indian journal of pathology & microbiology.

[5]  G. Gottlieb,et al.  Strongyloidiasis in transplant patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Saboya,et al.  Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation , 2009, Bone Marrow Transplantation.

[7]  J. Wingard,et al.  Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation , 2009, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  N. Ueno,et al.  Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation , 2006, Bone Marrow Transplantation.

[9]  K. Rolston,et al.  Strongyloidiasis in patients at a comprehensive cancer center in the United States , 2004, Cancer.

[10]  T. Nutman,et al.  Strongyloides stercoralis in the Immunocompromised Population , 2004, Clinical Microbiology Reviews.

[11]  E. Reisinger,et al.  Strongyloides stercoralis eggs in a urethral smear after bone marrow transplantation. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  S. Berk,et al.  Diagnosis of Strongyloides stercoralis infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. , 2001, Cytotherapy.

[14]  A. Armson,et al.  Murine strongyloidiasis: the effects of cyclosporin A and thiabendazole administered singly and in combination. , 1995, International journal for parasitology.

[15]  D S Ridley,et al.  Further observations on the formol-ether concentration technique for faecal parasites. , 1970, Journal of clinical pathology.